Evidence map›Paper›PMID 35045071›Full record

ArticlePloS one2022

Behavioral economic methods to inform infectious disease response: Prevention, testing, and vaccination in the COVID-19 pandemic.

Justin C Strickland, Derek D Reed, Steven R Hursh, Lindsay P Schwartz, Rachel N S Foster, Brett W Gelino, Robert S LeComte, Fernanda S Oda, Allyson R Salzer, Tadd D Schneider and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Interventions to increase COVID-19 vaccine uptake: a scoping review.The Cochrane database of systematic reviews · 2022
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Justin C StricklandDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.ORCID 0000-0003-1077-0394
Derek D ReedDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States of America.
Steven R HurshApplied Behavioral Biology Unit, Institutes for Behavior Resources, Baltimore, MD, United States of America.
Lindsay P SchwartzApplied Behavioral Biology Unit, Institutes for Behavior Resources, Baltimore, MD, United States of America.
Rachel N S FosterDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States of America.
Brett W GelinoDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States of America.
Robert S LeComteDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States of America.
Fernanda S OdaDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States of America.
Allyson R SalzerDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States of America.ORCID 0000-0003-2021-0729
Tadd D SchneiderDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States of America.
Lauren DaytonDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Carl LatkinDepartment of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States of America.
Matthew W JohnsonDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
University of Kansas · USJohns Hopkins University · USInstitutes for Behavior Resources · US

Funding

HUMAN BEHAVIORAL PHARMACOLOGY OF SUBSTANCE ABUSET32DA007209 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Eric C. Strain, Elise M Weerts · 1985 to 2026
$12.9M
Dose effects of nicotine: Behavioral economics of cigarette abuse liabilityR01DA042527 · NIDA · JOHNS HOPKINS UNIVERSITY · PI JOHNSON, MATTHEW WAYNE · 2016 to 2018
$2.1M
NIDA NIH HHS R01 DA042527NIDA NIH HHS T32 DA007209
6 · The paper itself

Abstract

The role of human behavior to thwart transmission of infectious diseases like COVID-19 is evident. Psychological and behavioral science are key areas to understand decision-making processes underlying engagement in preventive health behaviors. Here we adapt well validated methods from behavioral economic discounting and demand frameworks to evaluate variables (e.g., delay, cost, probability) known to impact health behavior engagement. We examine the contribution of these mechanisms within a broader response class of behaviors reflecting adherence to public health recommendations made during the COVID-19 pandemic. Four crowdsourced samples (total N = 1,366) completed individual experiments probing a response class including social (physical) distancing, facemask wearing, COVID-19 testing, and COVID-19 vaccination. We also measure the extent to which choice architecture manipulations (e.g., framing, opt-in/opt-out) may promote (or discourage) behavior engagement. We find that people are more likely to socially distance when specified activities are framed as high risk, that facemask use during social interaction decreases systematically with greater social relationship, that describing delay until testing (rather than delay until results) increases testing likelihood, and that framing vaccine safety in a positive valence improves vaccine acceptance. These findings collectively emphasize the flexibility of methods from diverse areas of behavioral science for informing public health crisis management.

Indexed as

Health BehaviorAdultCOVID-19COVID-19 TestingFemaleHumansMaleMasksMiddle AgedPandemicsPhysical DistancingRiskSARS-CoV-2Surveys and QuestionnairesVaccinationYoung Adult

Identifiers

PMID35045071
PMCPMC8769299
OpenAlexW4206377678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.